There is evidence of increased risk of myasthenia gravis following statin therapy. Here the authors investigated this association using electronic health records and suggest a minimum monitoring period of approximately six months for MG symptoms for patients starting using statins.
- Wanchun Xu
- Vincent Ka Chun Yan
- Eric Yuk Fai Wan
